Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2024)
Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -53.97% |
| Mar 31, 2024 | -12.89% |
| Dec 31, 2023 | -19.30% |
| Sep 30, 2023 | -23.95% |
| Jun 30, 2023 | 12.94% |
| Mar 31, 2023 | 15.90% |
| Dec 31, 2022 | -30.59% |
| Jun 30, 2022 | 51.57% |
| Mar 31, 2022 | -53.42% |
| Jun 30, 2021 | 12.94% |
| Jun 30, 2020 | -43.10% |
| Mar 31, 2020 | -24.57% |
| Sep 30, 2019 | -40.63% |
| Jun 30, 2019 | -18.47% |
| Mar 31, 2019 | -37.97% |
| Dec 31, 2018 | 61.54% |
| Sep 30, 2018 | 19.73% |
| Jun 30, 2018 | -35.07% |
| Mar 31, 2018 | -33.06% |
| Dec 31, 2017 | -6.19% |